ZNF331 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.426800E-01
Normal-vs-Stage2
9.831200E-01
Normal-vs-Stage3
6.986000E-01
Normal-vs-Stage4
9.580200E-01
Stage1-vs-Stage2
6.322800E-01
Stage1-vs-Stage3
6.406200E-01
Stage1-vs-Stage4
7.967000E-01
Stage2-vs-Stage3
6.964200E-01
Stage2-vs-Stage4
9.765600E-01
Stage3-vs-Stage4
7.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.239800E-01
Normal-vs-AfricanAmerican
6.254000E-01
Normal-vs-Asian
4.342200E-01
Caucasian-vs-AfricanAmerican
6.400800E-01
Caucasian-vs-Asian
1.423810E-01
AfricanAmerican-vs-Asian
1.233040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.625400E-01
Normal-vs-Female
8.218000E-01
Male-vs-Female
3.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.106800E-01
Normal-vs-Age(41-60Yrs)
6.877000E-01
Normal-vs-Age(61-80Yrs)
9.388800E-01
Normal-vs-Age(81-100Yrs)
6.997200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.442200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.160200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.456400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.339700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.191010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.529200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.015000E-01
Normal-vs-Daily Drinker
8.155600E-01
Normal-vs-Weekly Drinker
8.899800E-01
Normal-vs-Occasional Drinker
7.639600E-01
Normal-vs-Social Drinker
8.552200E-01
Non Drinker-vs-Daily Drinker
2.837200E-01
Non Drinker-vs-Weekly Drinker
3.545000E-01
Non Drinker-vs-Occasional Drinker
8.499200E-01
Non Drinker-vs-Social Drinker
7.717400E-01
Daily Drinker-vs-Weekly Drinker
7.994400E-01
Daily Drinker-vs-Occasional Drinker
3.533600E-01
Daily Drinker-vs-Social Drinker
4.371600E-01
Weekly Drinker-vs-Occasional Drinker
4.870000E-01
Weekly Drinker-vs-Social Drinker
6.053800E-01
Occasional Drinker-vs-Social Drinker
9.085000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.022200E-01
Normal-vs-Grade 2
8.297800E-01
Normal-vs-Grade 3
7.999000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.006200E-01
Grade 1-vs-Grade 3
1.821240E-01
Grade 1-vs-Grade 4
8.022200E-01
Grade 2-vs-Grade 3
5.640400E-01
Grade 2-vs-Grade 4
8.297800E-01
Grade 3-vs-Grade 4
7.999000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.046000E-01
Normal-vs-NonDiabetic
9.978200E-01
Diabetic-vs-NonDiabetic
7.489600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.793600E-01
Normal-vs-NoPancreatitis
9.784400E-01
Pancreatitis-vs-NoPancreatitis
5.355400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.446400E-01
Normal-vs-N1
9.564800E-01
N0-vs-N1
6.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.178400E-01
Normal-vs-TP53-NonMutant
9.657400E-01
TP53-Mutant-vs-TP53-NonMutant
8.646300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
